Literature DB >> 20083680

Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Gary F Mitchell1, Shih-Jen Hwang, Ramachandran S Vasan, Martin G Larson, Michael J Pencina, Naomi M Hamburg, Joseph A Vita, Daniel Levy, Emelia J Benjamin.   

Abstract

BACKGROUND: Various measures of arterial stiffness and wave reflection have been proposed as cardiovascular risk markers. Prior studies have not assessed relations of a comprehensive panel of stiffness measures to prognosis in the community. METHODS AND
RESULTS: We used proportional hazards models to analyze first-onset major cardiovascular disease events (myocardial infarction, unstable angina, heart failure, or stroke) in relation to arterial stiffness (pulse wave velocity [PWV]), wave reflection (augmentation index, carotid-brachial pressure amplification), and central pulse pressure in 2232 participants (mean age, 63 years; 58% women) in the Framingham Heart Study. During median follow-up of 7.8 (range, 0.2 to 8.9) years, 151 of 2232 participants (6.8%) experienced an event. In multivariable models adjusted for age, sex, systolic blood pressure, use of antihypertensive therapy, total and high-density lipoprotein cholesterol concentrations, smoking, and presence of diabetes mellitus, higher aortic PWV was associated with a 48% increase in cardiovascular disease risk (95% confidence interval, 1.16 to 1.91 per SD; P=0.002). After PWV was added to a standard risk factor model, integrated discrimination improvement was 0.7% (95% confidence interval, 0.05% to 1.3%; P<0.05). In contrast, augmentation index, central pulse pressure, and pulse pressure amplification were not related to cardiovascular disease outcomes in multivariable models.
CONCLUSIONS: Higher aortic stiffness assessed by PWV is associated with increased risk for a first cardiovascular event. Aortic PWV improves risk prediction when added to standard risk factors and may represent a valuable biomarker of cardiovascular disease risk in the community.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083680      PMCID: PMC2836717          DOI: 10.1161/CIRCULATIONAHA.109.886655

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

Authors:  S Laurent; P Boutouyrie; R Asmar; I Gautier; B Laloux; L Guize; P Ducimetiere; A Benetos
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

2.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

3.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry Aj Struijker Boudier; Alberto Zanchetti
Journal:  J Hypertens       Date:  2007-09       Impact factor: 4.844

4.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.

Authors:  Janaka Karalliedde; Andrew Smith; Lorenita DeAngelis; Vincenzo Mirenda; Albert Kandra; Jaco Botha; Philippe Ferber; Giancarlo Viberti
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

6.  Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study.

Authors:  Stanley S Franklin; Victor A Lopez; Nathan D Wong; Gary F Mitchell; Martin G Larson; Ramachandran S Vasan; Daniel Levy
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

Review 7.  Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage.

Authors:  Gary F Mitchell
Journal:  J Appl Physiol (1985)       Date:  2008-09-04

8.  Resistin, adiponectin, and risk of heart failure the Framingham offspring study.

Authors:  David S Frankel; Ramachandran S Vasan; Ralph B D'Agostino; Emelia J Benjamin; Daniel Levy; Thomas J Wang; James B Meigs
Journal:  J Am Coll Cardiol       Date:  2008-12-26       Impact factor: 24.094

9.  Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients.

Authors:  Piotr Jankowski; Kalina Kawecka-Jaszcz; Danuta Czarnecka; Malgorzata Brzozowska-Kiszka; Katarzyna Styczkiewicz; Magdalena Loster; Małgorzata Kloch-Badełek; Jerzy Wiliński; Adam M Curyło; Dariusz Dudek
Journal:  Hypertension       Date:  2008-02-11       Impact factor: 10.190

10.  Central blood pressure measurements and antihypertensive therapy: a consensus document.

Authors:  Enrico Agabiti-Rosei; Giuseppe Mancia; Michael F O'Rourke; Mary J Roman; Michel E Safar; Harold Smulyan; Ji-Guang Wang; Ian B Wilkinson; Bryan Williams; Charalambos Vlachopoulos
Journal:  Hypertension       Date:  2007-06-11       Impact factor: 10.190

View more
  718 in total

1.  Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1.

Authors:  Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster
Journal:  Circulation       Date:  2017-08-04       Impact factor: 29.690

2.  Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

Authors:  Bradley S Fleenor; Douglas R Seals; Melanie L Zigler; Amy L Sindler
Journal:  Aging Cell       Date:  2012-01-19       Impact factor: 9.304

3.  Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study.

Authors:  Gary F Mitchell; Mark A van Buchem; Sigurdur Sigurdsson; John D Gotal; Maria K Jonsdottir; Ólafur Kjartansson; Melissa Garcia; Thor Aspelund; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

4.  Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging.

Authors:  Amy L Sindler; Bradley S Fleenor; John W Calvert; Kurt D Marshall; Melanie L Zigler; David J Lefer; Douglas R Seals
Journal:  Aging Cell       Date:  2011-03-31       Impact factor: 9.304

Review 5.  Heart rate: a forgotten link in coronary artery disease?

Authors:  Kim M Fox; Roberto Ferrari
Journal:  Nat Rev Cardiol       Date:  2011-04-26       Impact factor: 32.419

6.  Role of TRPV4 in matrix stiffness-induced expression of EMT-specific LncRNA.

Authors:  Shweta Sharma; Li Ma; Shaik O Rahaman
Journal:  Mol Cell Biochem       Date:  2020-07-30       Impact factor: 3.396

7.  Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.

Authors:  Julio A Chirinos; Mayank Sardana; Amer Ahmed Syed; Maheshwara R Koppula; Swapna Varakantam; Izzah Vasim; Harold G Oldland; Timothy S Phan; Nadja E A Drummen; Cees Vermeer; Raymond R Townsend; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  J Am Soc Hypertens       Date:  2018-06-30

8.  Adiposity, but not Obesity, Is Associated With Arterial Stiffness in Young Nulliparous Women.

Authors:  Julie Phillips; Carole A McBride; Erin Morris; Abigail M Crocker; Ira Bernstein
Journal:  Reprod Sci       Date:  2017-09-01       Impact factor: 3.060

Review 9.  Noninvasive Imaging of Flow and Vascular Function in Disease of the Aorta.

Authors:  Matthew C Whitlock; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2015-09

Review 10.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.